Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/1998
06/11/1998WO1998024762A1 Vitamin d3 derivatives
06/11/1998WO1998024477A1 Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
06/11/1998WO1998024463A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
06/11/1998WO1998024437A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998CA2274250A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274249A1 Inhibitors of interleukin-1.beta. converting enzyme
06/11/1998CA2274145A1 Adaptor protein frs2 and related products and methods
06/11/1998CA2274048A1 Pyrazoles as human non-pancreatic secretory phospholipase a2 inhibitors
06/11/1998CA2273850A1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases
06/11/1998CA2273845A1 Secreted proteins and polynucleotides encoding them
06/11/1998CA2273002A1 Immunotherapeutic imides/amides as pde iv and tnf inhibitors
06/11/1998CA2272148A1 Vitamin d3 derivatives
06/10/1998EP0846687A1 Pyrazoles as human non-pancreatic secretory phospholipase A2 inhibitors
06/10/1998EP0846466A2 Compositions for the treatment of rheumatoid-based arthritic diseases
06/10/1998EP0846464A2 Use of glycogen phosphorylase inhibitor for reducing non-cardiac tissue damage resulting from ischemia
06/10/1998CN1183989A Buffering liquid for staphylococcus Aureus Injection and stephylococcus Aureus Injection with buffering liquid
06/10/1998CN1183986A Chinese medicine Pingguxiaociwan for curing Bi-syndrome
06/10/1998CN1183976A Hyperosteogeny curing medicine
06/10/1998CN1183975A Bi Syndrome curing medicine
06/10/1998CN1038680C Dihydronaphtho £1, 2-b| pyrane derivative and its producing process and use
06/09/1998US5763638 Preparation of aromatic nitriles
06/09/1998US5763611 Treating osteoporosis, rheumatoid arthritis
06/09/1998US5763569 Polypeptides as calcium receptors to generate antibodies
06/09/1998US5763567 Human amino acid sequences which can bind to and/or neutralize heparin
06/09/1998US5763416 Stimulating bone repair and regeneration
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763220 Human apoptosis-related calcium-binding protein
06/05/1998CA2223317A1 Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
06/04/1998WO1998023648A1 New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
06/04/1998WO1998023608A1 Novel integrin receptor antagonists
06/04/1998WO1998023588A1 Metalloproteinase inhibitors
06/04/1998WO1998023284A1 Method of regulating nitric oxide production
06/04/1998WO1998023274A1 Androgenic and bisphosphonic agents coadministered to treat diseases
06/04/1998WO1998023270A1 Pharmaceutical formulation
06/04/1998CA2272565A1 Integrin receptor antagonists
06/04/1998CA2271664A1 Androgenic and bisphosphonic agents coadministered to treat diseases
06/03/1998EP0845036A1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
06/03/1998EP0844874A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF $g(a) v?$g(b) 5? MEDIATED ANGIOGENESIS
06/03/1998CN1183805A Chemokine receptos 88-2B £CKR-3| and 88C and their antibodies
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183785A Novel peptides and remedy for bone diseases contg. same as active ingredient
06/03/1998CN1183287A Paste for treating spur
06/02/1998US5760214 Bone resorption inhibition/osteogenesis promotion compound
06/02/1998US5760083 Use of CLA to reduce the incidence of valgus and varus leg deforomities in poultry
06/02/1998US5760068 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/02/1998US5760035 Piperidine compounds substituted with an aminoalkyl group and an aryloxyalkyl group, antiallergens, antiinflammatory agents, immunosuppressants
06/02/1998US5759586 Mixture of sodium, potassium, magnesium and calcium (bi)carbonates and enzyme activators
05/1998
05/28/1998WO1998022501A2 Secreted proteins and polynucleotides encoding them
05/28/1998WO1998022465A1 A1 adenosine receptor antagonists
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022423A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998CA2272050A1 Secreted proteins and polynucleotides encoding them
05/28/1998CA2271963A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998CA2271767A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998CA2268770A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998CA2268041A1 Xanthines and their therapeutic use
05/28/1998CA2268037A1 Bicyclic aryl carboxamides and their therapeutic use
05/27/1998CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
05/27/1998CN1182599A Panacea oinment
05/26/1998US5756782 Suspending diacetylrhein in an organic solvent and water mixture, adding tertiary amine, then adding to the solution obtained, an caraboxylic acid salt of alkali or alkaline metals, hydrolyzing, collecting pure product by filtration
05/26/1998US5756530 3,4-substituted pyrazoles for the treatment of inflammation
05/26/1998US5756499 Substituted imidazole compounds
05/26/1998US5756489 18,19-dinor-vitamin D compounds
05/26/1998US5756465 Protease enzyme inhibitors
05/26/1998US5756084 Human stromal derived factor 1α and 1β
05/26/1998CA2136823C Phosphonosulfonate compounds for treating abnormal calcium and phosphate metabolism
05/22/1998WO1998021332A2 Secreted proteins and polynucleotides encoding them
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021236A1 Connective tissue growth factor-3
05/22/1998WO1998021195A1 Indene inhibitors of cox-2
05/22/1998WO1998021186A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998WO1998001555A3 Truncated soluble tumor necrosis factor type-i and type-ii receptors
05/22/1998CA2271116A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
05/22/1998CA2270908A1 Connective tissue growth factor-3
05/22/1998CA2270873A1 Secreted proteins and polynucleotides encoding them
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/22/1998CA2269035A1 Indene inhibitors of cox-2
05/20/1998EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein
05/20/1998EP0842945A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842944A2 Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842665A2 Interleukin-1 beta converting enzyme like apoptotic proteases and their agonists
05/20/1998EP0842274A1 Human mp52 arg protein
05/20/1998EP0842268A2 Methods and compositions for identifying morphogen analogs
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842169A1 Benzothiophene compounds
05/20/1998EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
05/20/1998EP0841929A1 Quinolones and their therapeutic use
05/19/1998US5753688 Antiinflammatory
05/19/1998US5753682 Imidazole lipoxygenase inhibitors
05/19/1998US5753266 Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
05/15/1998CA2220822A1 Heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020010A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
1 ... 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 ... 820